Episode Details

Back to Episodes

CAR-T cells are an expensive form of cancer treatment, but other techniques may soon supplant them, Elizabeth Tracey reports

Published 6 months, 1 week ago
Description
CAR-T cells, a highly activated immune cell, have been used to treat a solid tumor, stomach cancer, for the first time. Yet the fact remains that CAR-Ts are expensive and time consuming to produce. Johns Hopkins Kimmel Cancer Center director …

CAR-T cells are an expensive form of cancer treatment, but other techniques may soon supplant them, Elizabeth Tracey reports Read More »

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us